Inhibitors of dipeptidyl peptidase IV/CD26 suppress activation of human MBP-specific CD4 + T cell clones

Journal of Neuroimmunology

Volumn 87, Issue 1-2, 1998, Pages 203-209

  Reinhold, Dirk ^a,b   Hemmer, Bernhard ^b   Gran, Bruno ^b   Born, Ilona ^c   Faust, Jürgen ^c   Neubert, Klaus ^c   McFarland, Henry F ^b   Martin, Roland ^b   Ansorge, Siegfried ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Autoimmunity; CD26; Dipeptidyl peptidase IV; Inhibitors; Multiple sclerosis; Myelin basic protein; T lymphocyte

Indexed keywords

DIPEPTIDYL PEPTIDASE; MYELIN BASIC PROTEIN; PYRROLIDINE DERIVATIVE; THIAZOLIDINE DERIVATIVE;

ANIMAL CELL; ARTICLE; AUTOIMMUNITY; DNA SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGENS, CD26; ANTIGENS, CD4; CLONE CELLS; CYTOKINES; DNA; HUMANS; LYSINE; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEINS; PROTEASE INHIBITORS; PYRROLIDINES; T-LYMPHOCYTES; THIAZOLES;

EID: 0032127114     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00100-3     Document Type: Article

References (30)

1. Ansorge, S., Schön, E., Kunz, D., 1991. Membrane-bound peptidases of lymphocytes: functional implications. Biomed. Biochem. Acta 50, 799-807.
2. Bühling, F., Kunz, D., Reinhold, D., Ulmer, A.J., Ernst, M., Flad, H.-D., Ansorge, S., 1994. Expression and functional role of dipeptidyl peptidase IV on human natural killer cells. Nat. Immun. 13, 270-279.
3. Bühling, F., Junker, U., Reinhold, D., Neubert, K., Jäger, L., Ansorge, S., 1995. Functional role of CD26 on human B lymphocytes. Immunol. Lett. 45, 47-51.
4. Fleischer, B., 1994. CD26: a surface protease involved in T-cell activation. Immunol. Today 15, 180-184.
5. Fleischer, B., 1995. Dipeptidyl Peptidase IV (CD26) in metabolism and the Immune response. R.G. Landes, Austin.
6. Hegen, M., Niedobitek, C., Klein, C.E., Stein, H., Fleischer, B., 1990. The T cell triggering molecule Tp103 is associated with Dipeptidyl aminopeptidase IV activity. J. Immunol. 144, 2908-2914.
7. Kähne, T., Reinhold, D., Lendeckel, U., Bühling, F., Täger, M., Faust, J., Neubert, K., Ansorge, S., 1997. The effect of anti-CD26 antibodies on DNA synthesis and cytokine production (IL-2, IL-10, IFN-γ) depends on enzymatic activity of CD26/DP IV. Leukocyte Typing VI. Garland Publishing, New York, London, 485-487.
8. Korom, S., de Meester, I., Onodera, K., Stadlbauer, T.H.W., Borloo, M., Lambeir, A.M., Kupiec-Weglinski, J.W., 1997. The effects of CD26/DPP IV-targeted therapy on acute allograft rejection. Transplant. Proc. 29, 1274-1275.
9. Ling, N., Esch, F., Böhlen, P., Brazeau, P., Wehrenberg, W.B., Guillemin, R., 1984. Proc. Natl. Acad. Sci. U.S.A. 81, 4302.
10. Martin, R., McFarland, H.F., 1995. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit. Rev. Clin. Lab. Sci. 32, 121-182.
11. Martin, R., Utz, U., Coligan, J.E., Richert, J.R., Flerlage, M., Robinson, E., Stone, R., Biddison, W.E., McFarlin, D.E., McFarland, H.F., 1992. Diversity in fine specifity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. J. Immunol. 148, 1359-1366.
12. Mattern, T., Flad, H.-D., Feller, A.C., Heymann, E., Ulmer, A.J., 1989. Anti-DPP-IV and anti-Ta1 but not IOT 15 should be clustered in CDw26. In: Knapp, W., Dörken, B., Gilks, W.R., Rieber, E.P., Schmidt, R.E., Stein, H., von dem Borne, A.E.G.K. (Eds.), Leukocyte Typing IV. Oxford Univ. Press, Oxford, New York, Tokyo, p. 416.
13. Morimoto, C., Schlossman, S.F., 1994. A key costimulatory molecule on CD4 memory T cells. Immunologist 2, 4-7.
14. Reinhold, D., Bank, U., Bühling, F., Neubert, K., Mattern, T., Ulmer, A.J., Flad, H.-D., Ansorge, S., 1993. Dipeptidyl peptidase IV (CD26) on human lymphocytes. Synthetic inhibitors of and antibodies against dipeptidyl peptidase IV suppress the proliferation of pokeweed mitogen-stimulated peripheral blood mononuclear cells and IL-2 and IL-6 production. Immunobiology 188, 403-414.
15. Reinhold, D., Bank, U., Bühling, F., Kähne, T., Kunz, D., Faust, J., Neubert, K., Ansorge, S., 1994. Inhibitors of dipeptidyl peptidase IV (DP IV, CD26) specifically suppress proliferation and modulate cytokine production of strongly CD26 expressing U937 cells. Immunobiology 192, 121-136.
16. Reinhold, D., Bank, U., Bühling, F., Lendeckel, U., Faust, J., Neubert, K., Ansorge, S., 1997. Inhibitors of dipeptidyl peptidase IV induce secretion of transforming growth factor-β1 in PWM-stimulated PBMC and T cells. Immunology 91, 354-360.
17. Sachs, L., 1984. Angewandte Statistik. Springer-Verlag, Berlin, Heidelberg, New York, Tokyo.
18. Schön, E., Demuth, U.H., Barth, A., Ansorge, S., 1984. Dipeptidyl peptidase IV of human lymphocytes. Evidence for specific hydrolysis of glycylprolin in T-lymphocytes. Biochem. J. 223, 255-258.
19. Schön, E., Mansfeld, H.-W., Demuth, H.-U., Barth, A., Ansorge, S., 1985. The dipeptidyl peptidase IV, a membrane enzyme involved in the proliferation of T lymphocytes. Biomed. Biochem. Acta 44, K9-K15.
20. Schön, E., Eichmann, E., Grunow, R., Jahn, S., Kiessig, S.T., Volk, H.D., Ansorge, S., 1986. Dipeptidyl peptidase IV in human T lymphocytes. An approach to the role of a membrane peptidase in the immune system. Biomed. Biochem. Acta 45, 1523-1528.
21. Schön, E., Jahn, S., Kiessig, S.T., Demuth, H.-U., Neubert, K., Barth, A., von Baehr, R., Ansorge, S., 1987. The role of dipeptidyl peptidase IV in human T lymphocyte activation, inhibitors and antibodies against dipeptidyl peptidase IV suppress lymphocyte proliferation and immunoglobulin synthesis in vitro. Eur. J. Immunol. 17, 1821-1826.
22. Schön, E., Demuth, H.-U., Eichmann, E., Horst, H.-J., Körner, I.-J., Kopp, J., Mattern, T., Neubert, K., Noll, F., Ulmer, J.A., Barth, A., Ansorge, S., 1989. Dipeptidyl peptidase IV in human T lymphocytes impaired induction of interleukin 2 and gamma interferon due to specific inhibition of dipeptidyl peptidase IV. Scand. J. Immunol. 29, 127-132.
23. Schön, E., Born, I., Demuth, H.-U., Faust, J., Neubert, K., Steinmetzer, T., Barth, A., Ansorge, S., 1991. Dipeptidyl peptidase IV in the immune system. Effects of specific enzyme inhibitors on activity of dipeptidyl peptidase IV and proliferation of human lymphocytes. Biol. Chem. Hoppe-Seyler 372, 305-311.
24. Subramanyam, M., Gutheil, W.G., Bachovchin, W.W., Huber, B.T., 1993. Mechanism of HIV-1 Tat induced inhibition of antigen-specific T cell responsiveness. J. Immunol. 150, 2544-2553.
25. Tanaka, S., Murakami, T., Horikawa, H., Sugiura, M., Kawashima, K., Sugita, T., 1997. Suppression of arthritis by the inhibitors of dipeptidyl peptidase IV. Int. J. Immunopharmacol. 19, 15-24.
26. Ulmer, A.J., Mattern, T., Feller, A.C., Heymann, E., Flad, H.-D., 1990. CD26 antigen is a surface Dipeptidyl peptidase IV (DPPIV) as characterised by monoclonal antibodies clone TII-19-4-7 and 4EL1C1. Scand. J. Immunol. 31, 429-435.
27. Utz, U., Banks, D., Jacobson, S., Biddison, W.E., 1996. Analysis of the T cell receptor repertoire of human T cell leukemia virus type 1 (HTLV-1) tax-specific CD8+ cytotoxic T lymphocytes from patients with HTLV-1-associated disease: evidence for oligoclonal expansion. J. Virol. 70, 843.
28. Vanhoof, G., Goossens, F., DeMeester, I., Hendriks, D., Scharpe, S., 1995. Proline motifs in peptides and their biological progressing. FASEB J. 9, 736-744.
29. Vergelli, M., Hemmer, B., Utz, U., Vogt, A., Kalbus, M., Tranquill, L., Conlon, P., Ling, N., Steinman, L., McFarland, H.F., Martin, R., 1996. Differential activation of human autoreactive T cell clones by altered peptide ligands derived from myelin basic protein peptide (87-99). Eur. J. Immunol. 26, 2624-2634.
30. Yaron, A., Naider, F., 1993. Proline-dependent structural and biological properties of peptides and proteins. Crit. Rev. Biochem. Mol. Biol. 28, 31-81.